Current Opportunites

Emory School of Medicine Imagine, Innovate, and Impact (I3) Awards

The School of Medicine Imagine, Innovate, and Impact (I3) Awards accentuate the theme of innovation, complementing existing Woodruff Health Sciences Center supported Synergy awards, and fall into two categories in this initial round: (1) those focused on transformational research ideas (the I3 Wow! Research awards), and (2) those focused on novel ideas in medical education (the I3 Education awards).

Proposals are due October 15, 2018, by 5:00 p.m. Details can be found in the RFPs below:


A Call for Investigator-initiated Project Grants in Healthcare Innovation

The Emory-Georgia Tech Healthcare Innovation Program (HIP), in partnership with the Emory Synergy Award Program, Georgia CTSA, Emory Healthcare Innovation Hub, Emory Health Services Research Center, Winship Cancer Institute, Emory+Children’s Pediatrics Institute, and Georgia State University is pleased to announce the eleventh round of research seed grants in Healthcare Innovation. Seed grants will fund multi-investigator and multi-disciplinary teams examining healthcare services and clinical effectiveness. Awards will support innovative approaches that address issues of healthcare quality, costs, and/or access that are consistent with the goals of the Healthcare Innovation Program. 
Two types of grants will be offered: Preliminary Study Grants or Complete Project Grants. Click here for information regarding evaluation criteria, funding, proposal formats, and submission instructions. Research studies in health services and clinical effectiveness will be considered involving adult and/or pediatric patients.  
Letters of Intent due October 15, 2018
Proposals due November 15, 2018
The next Georgia CTSA RFP will be released by mid-January 2019. Please reference the 2018 RFP when planning your submission, as the guidelines will be similar.


The Pilot Grants program is a catalyst and vehicle for the transformation of clinical and translational science in Georgia. The program promotes new networks of multidisciplinary and inter-institutional research teams to re-engineer the health sciences enterprise of the city. The program enhances currently available resources from each Georgia CTSA partner by investing in new clinical and translational research paradigms, to encourage young faculty to develop cutting-edge science, and to become the glue that cements investigators and projects across the research consortium. Funding is used to support one to two year pilot projects consonant with the broad aims and objectives of the Georgia CTSA.

Pilot projects are intuitively understood to represent preliminary, preparatory, or feasibility studies designed to assess the applicability of new technologies, protocols, data collection instruments, or subject recruitment strategies as stepping-stones toward a full, hypothesis-testing investigation. The four academic institutional partners of the Georgia CTSA collectively recognize the critical need for start-up, feasibility, or proof-of-concept resources. Several pilot grant programs operate across each of the three academic institutions, providing resources to generate preliminary data and to demonstrate the feasibility of novel experimental tools and concepts. New investigators, more established scientists transitioning beyond their traditional pedagogic disciplines, and new collaborative teams of trans-disciplinary investigators are particularly dependent upon these sources of financial support.

Current Recipients


Upcoming Events

    View All Events

    Funding News


    Georgia CTSA Pilot Grants Program

    For over 10 years the Georgia CTSA Pilot Grants program has distributed grant funding to support one to two year pilot projects that advance and transform laboratory, clinic, and community observations into interventions that improve public and...


    Georgia CTSA-supported Finding: an `Achilles' heel' for the `Iraqibacter'

    Emory University microbiologists have found an “Achilles’ heel” for Acinetobacter baumannii, a type of disease-causing bacteria. Acinetobacter baumannii is known as “Iraqibacter,” because it is...